Novartis
Novartis to buy chronic pain drug developer Spinifex Pharmaceuticals
29 Jun 2015
Founded in 2005 and based in Stamford, Connecticut, USA, and Melbourne, Australia, Spinifex’ lead product is EMA401, under development as a potential first-in-class oral treatment for chronic pain without CNS side effects
HC backs Novartis, bars Cipla from selling lung drug copy
By By Jagdeep Worah | 10 Jan 2015
In a blow to those suffering from lung and respiratory diseases, the Delhi High Court on Friday restrained domestic firm Cipla from marketing its affordable generic version of respiratory drug Onbrez, ruling in favour of multinational Novartis
Novartis-GSK business deal gets CCI nod
23 Dec 2014
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Novartis, Google tie-up to license “smart lens” technology
16 Jul 2014
Novartis has tied-up with Google to licence its “smart lens” technology for ocular medical uses
Novartis AG, GSK in $23-bn assets swap deal
22 Apr 2014
Swiss drug giant Novartis AG and Britain's GlaxoSmithKline Plc (GSK) today announced a swap of assets in a deal valued at around $23 billion
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
May collaborate, not take over Roche: Novartis
03 Mar 2014
Novartis, which holds a third of Roche's bearer shares, has once again scotched reports of acquiring its Swiss rival, Roche
Bayer, Novartis, Reckitt Benckiser, P&G in fray for Merck & Co's consumer healthcare unit
20 Feb 2014
Bayer, Novartis, Reckitt Benckiser, and Procter & Gamble are among the companies that are exploring a deal to buy Merck &Co's consumer healthcare unit
Novartis arm faces criminal case in Japan over exaggerated advertising
09 Jan 2014
Under Japanese law, anyone found guilty of exaggerated advertising can be punished with up to two years in prison or a fine of as much as ¥2 million
After kickbacks to pharmacies, Novartis now sued for bribing US docs
27 Apr 2013
The new lawsuit this week comes just a few days after the US government slapped a civil health care fraud lawsuit against the Basel-based company for allegedly paying kickbacks to at least 20 pharmacies
Novartis loses patent battle in SC over cancer drug Glivec
01 Apr 2013
The Supreme Court on Monday dismissed Swiss drug multinational Novartis AG's attempt to win patent protection for its cancer drug Glivec, ending a seven-year battle over the issue
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "Microsoft, Google challenge Delhi HC order to remove non-consensual content")
